|
1
|
Pickens A and Orringer MB: Geographical
distribution and racial disparity in esophageal cancer. Ann Thorac
Surg. 76:S1367–S1369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qin HD, Liao XY, Chen YB, Huang SY, Xue
WQ, Li FF, Ge XS, Liu DQ, Cai Q, Long J, et al: Genomic
characterization of esophageal squamous cell carcinoma reveals
critical genes underlying tumorigenesis and poor prognosis. Am J
Hum Genet. 98:709–727. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun
ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, et al: Genetic landscape of
esophageal squamous cell carcinoma. Nat Genet. 46:1097–1102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang L, Zhou Y, Cheng C, Cui H, Cheng L,
Kong P, Wang J, Li Y, Chen W, Song B, et al: Genomic analyses
reveal mutational signatures and frequently altered genes in
esophageal squamous cell carcinoma. Am J Hum Genet. 96:597–611.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin DC, Hao JJ, Nagata Y, Xu L, Shang L,
Meng X, Sato Y, Okuno Y, Varela AM, Ding LW, et al: Genomic and
molecular characterization of esophageal squamous cell carcinoma.
Nat Genet. 46:467–473. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nishikura K: Functions and regulation of
RNA editing by ADAR deaminases. Annu Rev Biochem. 79:321–349. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maas S, Patt S, Schrey M and Rich A:
Underediting of glutamate receptor GluR-B mRNA in malignant
gliomas. Proc Natl Acad Sci USA. 98:14687–14692. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hogg M, Paro S, Keegan LP and O'Connell
MA: RNA editing by mammalian ADARs. Adv Genet. 73:87–120.
2011.PubMed/NCBI
|
|
11
|
Shah SP, Morin RD, Khattra J, Prentice L,
Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, et al:
Mutational evolution in a lobular breast tumour profiled at single
nucleotide resolution. Nature. 461:809–813. 2009. View Article : Google Scholar
|
|
12
|
Chen L, Li Y, Lin CH, Chan TH, Chow RK,
Song Y, Liu M, Yuan YF, Fu L, Kong KL, et al: Recoding RNA editing
of AZIN1 predisposes to hepatocellular carcinoma. Nat Med.
19:209–216. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang Q, Crews LA, Barrett CL, Chun HJ,
Court AC, Isquith JM, Zipeto MA, Goff DJ, Minden M, Sadarangani A,
et al: ADAR1 promotes malignant progenitor reprogramming in chronic
myeloid leukemia. Proc Natl Acad Sci USA. 110:1041–1046. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong
KJ, Liu M, Song Y, Chow RK, Ng VH, et al: A disrupted RNA editing
balance mediated by ADARs (Adenosine DeAminases that act on RNA) in
human hepatocellular carcinoma. Gut. 63:832–843. 2014. View Article : Google Scholar :
|
|
15
|
Qin YR, Qiao JJ, Chan TH, Zhu YH, Li FF,
Liu H, Fei J, Li Y, Guan XY and Chen L: Adenosine-to-inosine RNA
editing mediated by ADARs in esophageal squamous cell carcinoma.
Cancer Res. 74:840–851. 2014. View Article : Google Scholar
|
|
16
|
Galeano F, Rossetti C, Tomaselli S,
Cifaldi L, Lezzerini M, Pezzullo M, Boldrini R, Massimi L, Di Rocco
CM, Locatelli F, et al: ADAR2-editing activity inhibits
glioblastoma growth through the modulation of the
CDC14B/Skp2/p21/p27 axis. Oncogene. 32:998–1009. 2013. View Article : Google Scholar :
|
|
17
|
Evdokimova V, Tognon CE, Benatar T, Yang
W, Krutikov K, Pollak M, Sorensen PH and Seth A: IGFBP7 binds to
the IGF-1 receptor and blocks its activation by insulin-like growth
factors. Sci Signal. 5:ra922012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gommans WM, Tatalias NE, Sie CP, Dupuis D,
Vendetti N, Smith L, Kaushal R and Maas S: Screening of human SNP
database identifies recoding sites of A-to-I RNA editing. RNA.
14:2074–2085. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Levanon EY, Hallegger M, Kinar Y, Shemesh
R, Djinovic-Carugo K, Rechavi G, Jantsch MF and Eisenberg E:
Evolutionarily conserved human targets of adenosine to inosine RNA
editing. Nucleic Acids Res. 33:1162–1168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qi F, Cai P, Liu X, Peng M and Si G:
Adenovirus-mediated P311 inhibits TGF-β1-induced
epithelial-mesenchymal transition in NRK-52E cells via
TGF-β1-Smad-ILK pathway. Biosci Trends. 9:299–306. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim D, Pertea G, Trapnell C, Pimentel H,
Kelley R and Salzberg SL: TopHat2: Accurate alignment of
transcriptomes in the presence of insertions, deletions and gene
fusions. Genome Biol. 14:R362013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
DePristo MA, Banks E, Poplin R, Garimella
KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA,
Hanna M, et al: A framework for variation discovery and genotyping
using next-generation DNA sequencing data. Nat Genet. 43:491–498.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cingolani P, Patel VM, Coon M, Nguyen T,
Land SJ, Ruden DM and Lu X: Using Drosophila melanogaster as a
model for genotoxic chemical mutational studies with a new program,
SnpSift. Front Genet. 3:352012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li JB, Levanon EY, Yoon JK, Aach J, Xie B,
Leproust E, Zhang K, Gao Y and Church GM: Genome-wide
identification of human RNA editing sites by parallel DNA capturing
and sequencing. Science. 324:1210–1213. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu DQ, Li FF, Zhang JB, Zhou TJ, Xue WQ,
Zheng XH, Chen YB, Liao XY, Zhang L, Zhang SD, et al: Increased
RIPK4 expression is associated with progression and poor prognosis
in cervical squamous cell carcinoma patients. Sci Rep. 5:119552015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mutaguchi K, Yasumoto H, Mita K, Matsubara
A, Shiina H, Igawa M, Dahiya R and Usui T: Restoration of
insulin-like growth factor binding protein-related protein 1 has a
tumor-suppressive activity through induction of apoptosis in human
prostate cancer. Cancer Res. 63:7717–7723. 2003.PubMed/NCBI
|
|
27
|
Ruan W, Xu E, Xu F, Ma Y, Deng H, Huang Q,
Lv B, Hu H, Lin J, Cui J, et al: IGFBP7 plays a potential tumor
suppressor role in colorectal carcinogenesis. Cancer Biol Ther.
6:354–359. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vizioli MG, Sensi M, Miranda C, Cleris L,
Formelli F, Anania MC, Pierotti MA and Greco A: IGFBP7: An
oncosuppressor gene in thyroid carcinogenesis. Oncogene.
29:3835–3844. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Benatar T, Yang W, Amemiya Y, Evdokimova
V, Kahn H, Holloway C and Seth A: IGFBP7 reduces breast tumor
growth by induction of senescence and apoptosis pathways. Breast
Cancer Res Treat. 133:563–573. 2012. View Article : Google Scholar
|
|
30
|
Cenci C, Barzotti R, Galeano F, Corbelli
S, Rota R, Massimi L, Di Rocco C, O'Connell MA and Gallo A:
Down-regulation of RNA editing in pediatric astrocytomas: ADAR2
editing activity inhibits cell migration and proliferation. J Biol
Chem. 283:7251–7260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Godfried Sie C, Hesler S, Maas S and
Kuchka M: IGFBP7's susceptibility to proteolysis is altered by
A-to-I RNA editing of its transcript. FEBS Lett. 586:2313–2317.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada
N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M,
et al: Blockage of Ca(2+)-permeable AMPA receptors suppresses
migration and induces apoptosis in human glioblastoma cells. Nat
Med. 8:971–978. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ishiuchi S, Yoshida Y, Sugawara K, Aihara
M, Ohtani T, Watanabe T, Saito N, Tsuzuki K, Okado H, Miwa A, et
al: Ca2+-permeable AMPA receptors regulate growth of
human glioblastoma via Akt activation. J Neurosci. 27:7987–8001.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Imsumran A, Adachi Y, Yamamoto H, Li R,
Wang Y, Min Y, Piao W, Nosho K, Arimura Y, Shinomura Y, et al:
Insulin-like growth factor-I receptor as a marker for prognosis and
a therapeutic target in human esophageal squamous cell carcinoma.
Carcinogenesis. 28:947–956. 2007. View Article : Google Scholar
|
|
35
|
Riedmann EM, Schopoff S, Hartner JC and
Jantsch MF: Specificity of ADAR-mediated RNA editing in newly
identified targets. RNA. 14:1110–1118. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stulić M and Jantsch MF: Spatio-temporal
profiling of Filamin A RNA-editing reveals ADAR preferences and
high editing levels outside neuronal tissues. RNA Biol.
10:1611–1617. 2013. View Article : Google Scholar
|
|
37
|
Kanemitsu N, Kato MV, Miki T, Komatsu S,
Okazaki Y, Hayashizaki Y and Sakai T: Characterization of the
promoter of the murine mac25 gene. Biochem Biophys Res Commun.
279:251–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ahmed S, Yamamoto K, Sato Y, Ogawa T,
Herrmann A, Higashi S and Miyazaki K: Proteolytic processing of
IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its
biological activity. Biochem Biophys Res Commun. 310:612–618. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin J, Lai M, Huang Q, Ma Y, Cui J and
Ruan W: Methylation patterns of IGFBP7 in colon cancer cell lines
are associated with levels of gene expression. J Pathol. 212:83–90.
2007. View Article : Google Scholar : PubMed/NCBI
|
